Michael Matson
Stock Analyst at Needham
(1.66)
# 2,326
Out of 4,667 analysts
21
Total ratings
66.67%
Success rate
12.41%
Average return
Main Sectors:
Stocks Rated by Michael Matson
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TFX Teleflex | Maintains: Buy | $408 → $423 | $187.43 | +125.68% | 4 | Jan 31, 2020 | |
INGN Inogen | Upgrades: Buy | $90 | $9.46 | +851.37% | 2 | Nov 6, 2019 | |
MMSI Merit Medical Systems | Initiates: Buy | $53 | $104.08 | -49.08% | 1 | Apr 20, 2018 | |
GMED Globus Medical | Upgrades: Buy | n/a | $83.59 | - | 1 | Apr 4, 2018 | |
RMD ResMed | Upgrades: Hold | n/a | $241.55 | - | 1 | Jan 23, 2018 | |
BSX Boston Scientific | Upgrades: Strong Buy | n/a | $90.17 | - | 1 | Dec 8, 2017 | |
LIVN LivaNova | Upgrades: Buy | n/a | $50.05 | - | 2 | Sep 15, 2017 | |
SYK Stryker | Upgrades: Hold | n/a | $385.68 | - | 4 | Aug 25, 2017 | |
MBLY Mobileye | Downgrades: Hold | n/a | $16.92 | - | 1 | Mar 14, 2017 | |
HOLX Hologic | Upgrades: Buy | n/a | $78.04 | - | 2 | Feb 15, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.81 | - | 1 | Mar 3, 2016 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.56 | - | 1 | Feb 24, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $187.43
Upside: +125.68%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $9.46
Upside: +851.37%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $104.08
Upside: -49.08%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $83.59
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $241.55
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $90.17
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $50.05
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $385.68
Upside: -
Mobileye
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $16.92
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $78.04
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $2.81
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.56
Upside: -